510(k) Report

510(k) · Cleared

Cleared

MoniTorr ICP External Drainage and Monitoring System, LimiTorr Volume Limiting External CSF Drainage System

K191684510(k) TraditionalCleared Oct 11, 2019109-day reviewClass II21 CFR 882.5550

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Integra LifeSciences Corporation · JXG Shunt, Central Nervous System And Components

Cleared on Oct 11, 2019 as substantially equivalent to K920156 (Clinical Neuro Systems, LLC, 1992) and 2 other predicates after a 109-day review. Its family tree reaches back 3 generations to 1992. 3 of the 5 devices in its family, counting itself, have a Class I recall. 1 later device descends from it.

Decided
Oct 11, 2019
Review
109 days
Class
Class II
Product code
JXG
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K920156 (1992). 1 later device descends from it, 1 citing it directly. 3 of the 5 devices in this family, counting this one, have a Class I recall.

  1. Root · 3 generations backK920156 Clinical Neuro Syst Monitorr Ext CSF Drain/Moni SYClinical Neuro Systems, LLC · 1992 · Recalled (Class I)
  2. 2 generations backK022554 Monitorr Icp External CSF Drainage and Monitoring SystemIntegra Neurosciences · 2002 · Recalled (Class I)
  3. 1 generation backK072929 Limitorr Volume Limiting External CSF Drainage and Monitoring…Integra LifeSciences Corporation · 2007 · Recalled (Class I)
  4. This deviceK191684 MoniTorr ICP External Drainage and Monitoring System, LimiTorr…Integra LifeSciences Corporation · 2019
  5. Descendant · cites it directly · 0 of its ownK221694 External Drainage SystemJmed (Shenzhen) Technology Limited · 2023

Class I recalls in this family

Most influential descendants

Showing 1 of 1 · See all
  • K221694External Drainage SystemJmed (Shenzhen) Technology Limited · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K920156Clinical Neuro Syst Monitorr Ext CSF Drain/Moni SYClinical Neuro Systems, LLC1992Class I
−2K022554Monitorr Icp External CSF Drainage and Monitoring SystemIntegra Neurosciences2002Class I
−1K072929Limitorr Volume Limiting External CSF Drainage and Monitoring System, Models…Integra LifeSciences Corporation2007Class I
0 (this device)K191684MoniTorr ICP External Drainage and Monitoring System, LimiTorr Volume Limiting…Integra LifeSciences Corporation2019—
+1K221694External Drainage SystemJmed (Shenzhen) Technology Limited2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K191684, 1992–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

3 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JXG device

  1. #1 K243531 Codman Libertís Shunt Catheter with Bactiseal…score 11.9 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K920156Clinical Neuro Syst Monitorr Ext CSF Drain/Moni SY
Summary page 4
…JXG 807.92(a)(3) - Legally marketed device(s) to which equivalence is claimed MoniTorr ICP™ External Drainage and Monitoring Systems; K920156 / K022554 LimiTorr™ Volume Limiting External CSF Drainage Systems; K072929…
Clinical Neuro Systems, LLC1992Class I
*K022554Monitorr Icp External CSF Drainage and Monitoring System
Summary page 4
…JXG 807.92(a)(3) - Legally marketed device(s) to which equivalence is claimed MoniTorr ICP™ External Drainage and Monitoring Systems; K920156 / K022554 LimiTorr™ Volume Limiting External CSF Drainage Systems; K072929…
Integra Neurosciences2002Class I
*K072929Limitorr Volume Limiting External CSF Drainage and Monitoring System, Models INS9020…
Summary page 4
…which equivalence is claimed MoniTorr ICP™ External Drainage and Monitoring Systems; K920156 / K022554 LimiTorr™ Volume Limiting External CSF Drainage Systems; K072929 3DJHRI ,QWH…
Integra LifeSciences Corporation2007Class I

Also cleared against K920156: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K221694External Drainage SystemJmed (Shenzhen) Technology Limited20230

Has anything in its family been recalled? (3 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K072929Limitorr Volume Limiting External CSF Drainage and Monitoring System, Models INS9020, INS9030Integra LifeSciences Corporation · 2007 · Direct predicate · ◆ on the line of descent in FIG. 11 Class I recall
  • K022554Monitorr Icp External CSF Drainage and Monitoring SystemIntegra Neurosciences · 2002 · Direct predicate · ◆ on the line of descent in FIG. 12 Class I recalls
  • K920156Clinical Neuro Syst Monitorr Ext CSF Drain/Moni SYClinical Neuro Systems, LLC · 1992 · Direct predicate · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 27 years and passes through 3 companies; a new generation was cleared every 10.4 years on median.
  • 3 of the 3 ancestors have a recall of any class; 3 have a Class I recall.
  • Of its descendants, K221694 (Jmed (Shenzhen) Technology Limited, 2023) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K920156.

How does its category compare?

All JXG devices

JXG Shunt, Central Nervous System And Components: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · JXG

8in 2025

2007: 32008: 62009: 52010: 32011: 72012: 32013: 32015: 62016: 62017: 72018: 62019: 42020: 22021: 12022: 42023: 52024: 32025: 82026 (partial year): 2
2007high 8 (2025) · low 0 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JXG

255in 2025

2007: 184 days median2008: 60 days median2009: 106 days median2010: 30 days median2011: 136 days median2012: 78 days median2013: 108 days median2015: 276 days median2016: 143 days median2017: 90 days median2018: 102 days median2019: 101 days median2022: 101 days median2023: 134 days median2024: 90 days median2025: 255 days median
2007high 276 (2015) · low 30 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JXG

3in 2024

2008: 12009: 302011: 52012: 12013: 142014: 62017: 12020: 82023: 22024: 32026 (partial year): 1
2007high 30 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JXG

1,198in 2025

2007: 6492008: 6302009: 6292010: 8122011: 7872012: 9772013: 1,0042014: 1,2512015: 9842016: 1,0912017: 1,3352018: 1,4842019: 1,2952020: 1,2062021: 1,4672022: 1,3292023: 1,2212024: 1,2142025: 1,198
2007high 1,484 (2018) · low 629 (2009)2025

MAUDE reports naming product code JXG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200731840649
20086601630
2009510630629
20103300812
201171365787
20123781977
20133108141,004
20140—61,251
201562760984
2016614301,091
201779011,335
2018610201,484
2019410101,295
20202—81,206
20211—01,467
2022410101,329
2023513421,221
202439031,214
2025825501,198
20262—1—

What is it indicated for?

The MoniTorr ICP™ system allows for drainage and monitoring of CSF from the lateral ventricles of the brain and the lumbar subarachnoid space in selected patients to reduce intracranial pressure (ICP), to monitor CSF, to provide temporary drainage of CSF in patients with infected CSF shunts, and the monitoring of ICP.

The LimiTorr™ system allows for drainage and monitoring of CSF from the lateral ventricles of the brain and the lumbar subarachnoid space in selected patients to reduce intracranial pressure (ICP), to monitor CSF, to provide temporary drainage of CSF in patients with infected CSF shunts, and to monitor ICP.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K191684: MoniTorr ICP External Drainage and Monitoring System, LimiTorr Volume Limiting External CSF Drainage System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K191684

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026